GLAXO’s IMITREX FOR MIGRAINE WILL BE AVAILABLE IN MARCH AFTER DEC. 28 APPROVAL; FIRM WILL CONDUCT PHASE IV STUDY IN PREGNANT WOMEN IN LIEU OF REGISTRY